66 research outputs found
Adequate vitamin B12 and folate status of Norwegian vegans and vegetarians
Plant-based diets may increase the risk of vitamin B12 deficiency due to limited intake of animal-source foods, while dietary folate increases when adhering to plant-based diets. In this cross-sectional study, we evaluated the B12 and folate status of Norwegian vegans and vegetarians using dietary B12 intake, B12- and folic acid supplement use, and biomarkers (serum B12 [B12], plasma total-homocysteine [tHcy], plasma-methylmalonic acid [MMA], and serum-folate). Vegans (n=115) and vegetarians (n=90) completed a 24-hour dietary recall and a food-frequency questionnaire and provided a non-fasting blood sample. cB12, a combined indicator for evaluation of B12 status, was calculated. B12 status were adequate in both vegans and vegetarians according to the cB12 indicator, however 4% had elevated B12. Serum B12, tHcy, MMA concentrations and the cB12 indicator (overall median: 357pmol/L, 9.0µmol/L, 0.18µmol/L, 1.30 (cB12)) did not differ between vegans and vegetarians, unlike for folate (vegans: 25.8nmol/L, vegetarians: 21.6nmol/L, p=0.027). Serum B12 concentration <221pmol/L, was found in 14% of all participants. Vegetarians revealed the highest proportion of participants below the RDI of 2 µg/day including supplements (40 vs. 18%, p<0.001). Predictors of higher serum B12 concentrations were average daily supplement use and older age. Folate deficiency (<10 nmol/L) was uncommon overall (<2.5%). The combined indicator cB12 suggested that none of the participants was B12 depleted, however low serum B12 concentration was found in 14% of the participants. Folate concentrations were adequate, indicating adequate folate intake in Norwegian vegans and vegetarians.publishedVersionPaid open acces
Recommended from our members
Infant Serum and Maternal Milk Vitamin B-12 Are Positively Correlated in Kenyan Infant-Mother Dyads at 1-6 Months Postpartum, Irrespective of Infant Feeding Practice.
BackgroundVitamin B-12 is an essential nutrient required for many functions including DNA synthesis, erythropoiesis, and brain development. If maternal milk vitamin B-12 concentrations are low, infants may face elevated risks of deficiency when exclusively breastfed.ObjectiveWe evaluated cross-sectional associations between infant serum vitamin B-12 concentrations and maternal milk vitamin B-12 concentrations at 1-6 mo postpartum among an unsupplemented population in rural western Kenya, and assessed biological demographic, and dietary characteristics associated with adequate infant serum vitamin B-12.MethodsWe modeled 1) infant serum vitamin B-12 using maternal milk vitamin B-12 concentration with linear regression; and 2) adequate (>220 pmol/L) infant serum vitamin B-12 using hypothesized biological, demographic, and dietary predictors with logistic regression. In both models, we used generalized estimating equations to account for correlated observations at the cluster-level.ResultsThe median (quartile 1, quartile 3) infant serum vitamin B-12 concentration was 276 pmol/L (193, 399 pmol/L) and approximately one-third of infants had serum vitamin B-12 ≤220 pmol/L, indicating that they were vitamin B-12 depleted or deficient. There was a positive correlation between maternal milk and infant serum vitamin B-12 (r = 0.36, P < 0.001) and in multivariable analyses, maternal milk vitamin B-12 concentration was significantly associated with infant serum vitamin B-12 adequacy (P-trend = 0.03).ConclusionsDespite a high prevalence (90%) of maternal milk vitamin B-12 concentrations below the level used to establish the Adequate Intake (<310 pmol/L), there was a low prevalence of infant vitamin B-12 deficiency. We found few factors that were associated with infant vitamin B-12 adequacy in this population, including infant feeding practices, although maternal vitamin B-12 status was not measured. The contribution of maternal milk to infant vitamin B-12 status remains important to quantify across populations, given that maternal milk vitamin B-12 concentration is modifiable with supplementation. This trial was registered at clinicaltrials.gov as NCT01704105
Vitamin B12 concentrations in milk from Norwegian women during the six first months of lactation
Background: Human milk vitamin B12 (B12) concentrations depend on maternal status and intake; only few data are available in high-income countries. Objective: We assessed human milk B12 concentrations during the first 6 months postpartum in Norwegian women and its association with maternal dietary B12 intake and maternal urinary methylmalonic acid (MMA) concentration. Methods: In this cross-sectional study, 175 mothers, exclusively (80%) or partially (20%) breastfeeding, were included. Milk B12 was measured by IMMULITE®/IMMULITE® 1000 B12 competitive protein binding assay and urinary MMA relative to creatinine (MMA/Cr) by liquid chromatography-tandem-mass spectrometry. Maternal habitual B12 intake and supplement use were estimated using a food frequency questionnaire. Results: Mean human milk B12 concentration was 327 pmol/L (range 140-1089), with 402 pmol/L at 1 month (n = 21), 333 pmol/L at four months (n = 32), and 299 pmol/L at 6 months (n = 21). Maternal B12 intake was 5 µg/d, 89% met the Estimated Average Requirement, and supplement use did not affect milk B12 concentrations. MMA/Cr was low in all women compared with published data. In exclusively breastfeeding women, MMA/Cr (beta (95% CI) -42.5 (-82.5, -2.5) and time since birth (-4.9 (-9.6, -0.3)) were significant predictors of human milk B12 concentrations. There was no association between total B12 intake and milk B12 concentration or between total B12 intake and MMA/Cr. Conclusions: Maternal B12 status and human milk B12 concentrations are likely sufficient, based on adequate maternal B12 dietary intake combined with low urinary MMA concentrations. Nevertheless, milk B12 concentration fell during 6 months postpartum while maternal B12 status did not change.publishedVersio
Predicted efficacy of the Palestinian wheat flour fortification programme: complementary analysis of biochemical and dietary data
Objective: To utilize complementary biochemical and dietary data collected before the initiation of national flour fortification to (i) identify micronutrient insufficiencies or deficiencies and dietary inadequacies in Palestinian women and children in vulnerable communities and (ii) assess the suitability of the current wheat flour fortification formula. Design: Quantitative dietary intake questionnaires were administered and fasting venous blood samples collected in randomly selected households in Gaza City and Hebron. The impact of fortification was simulated by estimating the additional micronutrient content of fortified wheat flour. Setting: Households in Gaza City and Hebron that were not receiving food aid from social programmes. Subjects: Non-pregnant women (18–49 years) and children aged 36–83 months. Results: The micronutrients with highest prevalence of insufficiency were vitamin D in women (84–97 % with serum 25-hydroxyvitamin D \u3c50 nmol/l) and vitamin B12 in women and children (43–82 % with serum B12 \u3c221 pmol/l). Deficiencies of vitamin A, Fe and Zn were also of public health concern. Current levels of wheat flour fortificants were predicted to improve, but not eliminate, micronutrient intake inadequacies. Modification of fortificant concentrations of vitamin D, thiamin, vitamin B12, Zn and folic acid may be indicated. Conclusions: Micronutrient insufficiencies or deficiencies and intake inadequacies were prevalent based on either biochemical or dietary intake criteria. Adjustments to the current fortification formula for wheat flour are necessary to better meet the nutrient needs of Palestinian women and children
Predicted efficacy of the Palestinian wheat flour fortification programme: complementary analysis of biochemical and dietary data
To utilize complementary biochemical and dietary data collected
before the initiation of national flour fortification to (i) identify micronutrient
insufficiencies or deficiencies and dietary inadequacies in Palestinian women and
children in vulnerable communities and (ii) assess the suitability of the current
wheat flour fortification formula.
Design: Quantitative dietary intake questionnaires were administered and fasting
venous blood samples collected in randomly selected households in Gaza City
and Hebron. The impact of fortification was simulated by estimating the additional
micronutrient content of fortified wheat flour.
Setting: Households in Gaza City and Hebron that were not receiving food aid
from social programmes.
Subjects: Non-pregnant women (18–49 years) and children aged 36–83 months.
Results: The micronutrients with highest prevalence of insufficiency were vitamin
D in women (84–97 % with serum 25-hydroxyvitamin D <50 nmol/l) and vitamin
B12 in women and children (43–82 % with serum B12 <221 pmol/l). Deficiencies of
vitamin A, Fe and Zn were also of public health concern. Current levels of wheat
flour fortificants were predicted to improve, but not eliminate, micronutrient
intake inadequacies. Modification of fortificant concentrations of vitamin D,
thiamin, vitamin B12, Zn and folic acid may be indicated.
Conclusions: Micronutrient insufficiencies or deficiencies and intake inadequacies
were prevalent based on either biochemical or dietary intake criteria. Adjustments
to the current fortification formula for wheat flour are necessary to better meet the
nutrient needs of Palestinian women and children.Financial support: This article was made possible by the
generous support of the US Agency for International Development (USAID) under the terms of Cooperative
Agreement No. GHS-A-00-05-00012-00 to FHI-360 (and
before to AED). USAID had no role in the design, analysis,
or writing of this article. Conflict of interest: None.
Authorship: Z.A. was responsible for field work and data
collection, and contributed in interpretation of results.
A.’A.A. contributed in the interpretation of the results.
L.H.A. advised the project, supervised biochemical analyses
and assisted with data interpretation and publication.
A.C. calculated estimates of usual food and nutrient intakes.
O.D. acted as study coordinator. S.D. was responsible for
field work and data collection. D.D. assisted with data
interpretation and was responsible for manuscript preparation.
R.Q. entered and cleaned data, and assisted with
statistical analysis. Z.R. carried out statistical analyses. A.R.
assisted with study design and liaised with the Ministry of
Health of the Palestinian Authority. R.S. facilitated transfer of
biological specimens and coordinated data analysis. S.S.-F.
conducted biochemical analyses of the serum samples.
Ethics of human subject participation: The study was
conducted according to the guidelines laid down in the
Declaration of Helsinki and all procedures involving
human subjects were approved by the Committee on
Human Subjects Research at the Directorate of Primary
Health Care and Public Health of the Ministry of Health of
the Palestinian Authority, as well as the Office of Research
of Al-Quds University
Daily supplementation of a multiple micronutrient powder improves folate but not thiamine, riboflavin, or vitamin B <sub>12</sub> status among young Laotian children:a randomized controlled trial
PURPOSE: To assess the effects of intervention with a daily multiple micronutrient powder (MNP) on thiamine, riboflavin, folate, and B(12) status among young Laotian children. METHODS: Children (n = 1704) aged 6–23 mo, participating in a double-blind placebo-controlled randomized trial were individually randomized to receive daily either MNP (containing 0.5 mg of thiamine, 0.5 mg riboflavin, 150 μg folic acid, and 0.9 μg vitamin B(12) along with 11 other micronutrients) or placebo and followed for ~ 36 weeks. In a randomly selected sub-sample of 260 children, erythrocyte thiamine diphosphate (eThDP), plasma folate and B(12) concentrations, and erythrocyte glutathione reductase activation coefficient (EGRac; riboflavin biomarker) were assessed at baseline and endline. RESULTS: There was no treatment effect on endline eThDP concentrations (110.6 ± 8.9 nmol/L in MNP vs. 109.4 ± 8.9 nmol/L in placebo group; p = 0.924), EGRac (1.46 ± 0.3 vs. 1.49 ± 0.3; p = 0.184) and B(12) concentrations (523.3 ± 24.6 pmol/L vs. 515.9 ± 24.8 pmol/L; p = 0.678). Likewise, the prevalence of thiamine, riboflavin, and B(12) deficiencies did not differ significantly between the two groups. However, endline folate concentration was significantly higher in the MNP compared to the placebo group (28.2 ± 0.8 nmol/L vs 19.9 ± 0.8 nmol/L, respectively; p < 0.001), and correspondingly, the prevalence of folate deficiency was significantly lower in the MNP group (1.6% vs 17.4%; p = 0.015). CONCLUSIONS: Compared to a placebo, daily MNP for 9 months increased only folate but not thiamine, riboflavin, or B(12) status in young Laotian children. TRIAL REGISTRATION: The trial was registered at www.clinicaltrials.gov (NCT02428647) on April 29 2015
Thiamin and Riboflavin in Human Milk: Effects of Lipid-Based Nutrient Supplementation and Stage of Lactation on Vitamer Secretion and Contributions to Total Vitamin Content
While thiamin and riboflavin in breast milk have been analyzed for over 50 years, less attention has been given to the different forms of each vitamin. Thiamin-monophosphate (TMP) and free thiamin contribute to total thiamin content; flavin adenine-dinucleotide (FAD) and free riboflavin are the main contributors to total riboflavin. We analyzed milk collected at 2 (n = 258) or 6 (n = 104), and 24 weeks (n = 362) from HIV-infected Malawian mothers within the Breastfeeding, Antiretrovirals and Nutrition (BAN) study, randomly assigned at delivery to lipid-based nutrient supplements (LNS) or a control group, to investigate each vitamer’s contribution to total milk vitamin content and the effects of supplementation on the different thiamin and riboflavin vitamers at early and later stages of lactation, and obtain insight into the transport and distribution of these vitamers in human milk. Thiamin vitamers were derivatized into thiochrome-esters and analyzed by high-performance liquid-chromatography-fluorescence-detection (HPLC-FLD). Riboflavin and FAD were analyzed by ultra-performance liquid-chromatography-tandem-mass-spectrometry (ULPC-MS/MS). Thiamin-pyrophosphate (TPP), identified here for the first time in breast milk, contributed 1.9–4.5% to total thiamin. Free thiamin increased significantly from 2/6 to 24 weeks regardless of treatment indicating an active transport of this vitamer in milk. LNS significantly increased TMP and free thiamin only at 2 weeks compared to the control: median 170 versus 151μg/L (TMP), 13.3 versus 10.5μg/L (free thiamin, p<0.05 for both, suggesting an up-regulated active mechanism for TMP and free thiamin accumulation at early stages of lactation. Free riboflavin was consistently and significantly increased with LNS (range: 14.8–19.6μg/L (LNS) versus 5.0–7.4μg/L (control), p<0.001), shifting FAD:riboflavin relative amounts from 92–94:6–8% to 85:15%, indicating a preferred secretion of the free form into breast milk. The continuous presence of FAD in breast milk suggests an active transport and secretion system for this vitamer or possibly formation of this co-enymatic form in the mammary gland
Antiretroviral therapy provided to HIV-infected Malawian women in a randomized trial diminishes the positive effects of lipid-based nutrient supplements on breast-milk B vitamins
Background: Little information is available on B vitamin concentrations in human milk or on how they are affected by maternal B vitamin deficiencies, antiretroviral therapy, or maternal supplementation
- …